Eli Lilly's Mounjaro drug has become India's top seller for October as sales reached one billion rupees. This anti-obesity medication helps control blood sugar and slows digestion. Demand for such drugs is increasing in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MFQHWda
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(741)
-
▼
November
(45)
- Quality issues: Regulator looks to tighten marketi...
- Eli Lilly wants to be part of making a big dent in...
- Ultra-processed foods displacing fresh meals world...
- Novo Nordisk India prioritises patient outcomes; r...
- After cough syrup deaths, drug regulator moves to ...
- NCLT clears Sequent Scientific–Viyash Life Science...
- Patent expiry looms: Eli Lilly and Novo Nordisk st...
- Import price floor on cards for critical pharma in...
- Deep Diamond India to enter preventive healthcare ...
- Pfizer launches new medication for migraine treatment
- AI tool in national disease surveillance helped is...
- Wealth Whisperers: Meet wealth psychologists who h...
- Three-day pharma industry event from Nov 25 to hos...
- Lupin launches generic injection in US with 180-da...
- Small pharma firms may face closure as regulator t...
- Biocon considers merging Biocon Biologics in $4.5 ...
- Eli Lilly drops CVS drug plan for staff after Novo...
- NTPC inks two pacts in Assam; to build burn ICU at...
- Lupin unit commissions oncology block at Vizag pla...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% ...
- Novo, Emcure to launch weight-loss drug under new ...
- Novo Nordisk ties up with Emcure to expand reach o...
- Novo Nordisk, Emcure to launch weight-loss drug un...
- Cyber fraud: Dr Reddy's Laboratories loses Rs 2.16...
- Apollo’s Suneeta Reddy and Dr Preetha Reddy on the...
- Centre asks states to take steps to encourage orga...
- Venus Remedies gets new market authorisations for ...
- Metsera accepts Pfizer's $10 billion bid in ongoin...
- Drug regulator for strict compliance with new Sche...
- Alembic Pharmaceuticals gets USFDA nod for generic...
- Obesity drug Mounjaro becomes India's top-selling ...
- 'Opaque pricing cripples Ayushman drug coverage'
- Apollo Hospitals eyes Q4 FY26 listing for HealthCo...
- Bayer gets nod to market Kerendia for heart failur...
- Sun Pharma’s US innovative drug sales surpass gene...
- Zydus gets USFDA's orphan drug designation for bet...
- Sun Pharma's US innovative drug sales surpass gene...
- Novelis says September fire at New York plant to h...
- Novelis expects cash flow impact of up to $650 mn ...
- Knee implant ceiling rates to be reviewed
- Glenmark to launch generic drug to treat metabolic...
- Novo sharpens India focus with bigger bets on nich...
- Cipla to fully acquire Inzpera Healthscience
- AIMS hospital founder looks to buy back PE investo...
- AI helping doctors spend more time with patients, ...
-
▼
November
(45)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment